Sihuan Pharmaceut.

View in Terminal

Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics

In 2026, Sihuan Pharmaceut. has already paid €0.00121 in dividends. The last payout was in July.

Financials

In the last quarter, Sihuan Pharmaceut. had revenue of €149.76M and net profit of €28.98M

(EUR)	June 2026	YoY
Revenue	149.76M	-
Gross profit	87.91M	-
Net profit	28.98M	-
EBITDA	40.9M	-

Fundamentals

Metric	Value
Market capitalization	€742.51M
Number of shares	9B
52-week high/low	€0.20 - €0.078
Dividend yield	1.50%
Dividends TTM	€0.00121
Beta	0.87
P/E ratio	18.38
PEG ratio	0.03
P/B ratio	0.90
P/S ratio	2.10

Company profile

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in the People's Republic of China. It offers drugs in the oncology, metabolic diseases, digestive system, and other therapeutic areas. The company is also involved in the investment and sale of medical beauty products; manufacture of medical instruments; investment in properties; construction for medical projects; and project preparation for pharmaceutical products manufacturing. In addition, it provides information support, general hospital, hospital management, biotechnology promotion, and medical aesthetic research and development services. The company was founded in 2001 and is based in Wanchai, Hong Kong.